Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-Drug Resistant Tuberculosis”

131 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 131 results

Not applicableUnknownNCT03827811
What this trial is testing

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Who this might be right for
Multi-drug Resistant Tuberculosis
University of Cape Town 625
Not applicableStudy completedNCT02816931
What this trial is testing

Drug Concentrations in the Treatment of MDR-TB Related to Minimum Inhibitory Concentrations

Who this might be right for
Tuberculosis, Multidrug Resistant
Karolinska Institutet 37
Not applicableStudy completedNCT00341601
What this trial is testing

Multi-Drug Resistant Tuberculosis in Korea

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 777
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00910871
What this trial is testing

To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.

Who this might be right for
Tuberculosis
Janssen Infectious Diseases BVBA 241
Not applicableStudy completedNCT03470233
What this trial is testing

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

Who this might be right for
Multi-drug Resistant Tuberculosis
Korea Otsuka Pharmaceutical Co., Ltd. 149
Post-approval studies (Phase 4)Looking for participantsNCT05493267
What this trial is testing

A Exploratory Study of Vγ2Vδ2 T Lymphocyte-based Immunotherapy for MDR-TB

Who this might be right for
MDR-TBImmunotherapy
Shanghai Pulmonary Hospital, Shanghai, China 30
Testing effectiveness (Phase 2)Study completedNCT02619994
What this trial is testing

Treatment Shortening of MDR-TB Using Existing and New Drugs

Who this might be right for
Tuberculosis, Multidrug-Resistant
Seoul National University Hospital 214
Not applicableStudy completedNCT03000517
What this trial is testing

PK of Levofloxacin in MDR-TB Patients

Who this might be right for
Multi-drug Resistant Tuberculosis
University Medical Center Groningen 20
Not applicableStudy completedNCT07167823
What this trial is testing

The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront

Who this might be right for
Pleural EmpyemaTuberculosis (TB)Bacterial Sepsis
University of Health Sciences Lahore 350
Not applicableUnknownNCT04397536
What this trial is testing

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis

Who this might be right for
Multi-Drug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 172
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Not applicableStudy completedNCT03259269
What this trial is testing

Expand New Drugs for TB [endTB]

Who this might be right for
Tuberculosis, Multidrug-Resistant
Partners in Health 2,804
Testing effectiveness (Phase 2)UnknownNCT05077813
What this trial is testing

Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosolized), Minocycline and Vitamin D as a Potent Quadrate Therapy for Treating Patients With Multidrug-resistant TB and Patient With Both Multidrug-resistant TB and COVID-19

Who this might be right for
Tuberculosis
Kafrelsheikh University 250
Large-scale testing (Phase 3)Study completedNCT01977768
What this trial is testing

TB Immunotherapy Trial With Heat-killed M. Vaccae

Who this might be right for
Tuberculosis
Immunitor LLC 152
Not applicableStudy completedNCT07003581
What this trial is testing

Cardiometabolic Risk Factors Associated With Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis (TB)
B.P. Koirala Institute of Health Sciences 183
Not applicableStudy completedNCT02169141
What this trial is testing

Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients

Who this might be right for
Tuberculosis
University Medical Center Groningen 20
Not applicableStudy completedNCT07058233
What this trial is testing

Oral Nutritional Supplementation and Weight Changes During Therapy in Malnourished Patients With Resistant Tuberculosis: A Clinical Trial

Who this might be right for
Tuberculosis Multi Drug Resistant ActiveRifampin-Resistant Pulmonary TuberculosisPre-xdr tb
RSUP Persahabatan 70
Large-scale testing (Phase 3)Looking for participantsNCT05081401
What this trial is testing

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Who this might be right for
Multidrug Resistant TuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital 1,050
Not applicableStudy completedNCT02984579
What this trial is testing

Line Probe Assay Evaluation Study

Who this might be right for
Multidrug-Resistant TuberculosisIsoniazid Resistant Pulmonary TuberculosisRifampicin Resistant Tuberculosis+1 more
Foundation for Innovative New Diagnostics, Switzerland 888
Next Page